Literature DB >> 14718608

Reduced expression of organic cation transporters rOCT1 and rOCT2 in experimental diabetes.

Brett Grover1, Donna Buckley, Arthur R Buckley, William Cacini.   

Abstract

Recent reports have documented a functional deficit of organic cation transport in diabetic rats by an unknown mechanism. This study was designed to test the hypothesis that experimental diabetes decreases expression of organic cation transporters at the basolateral membrane. Streptozotocin-induced diabetic rats were maintained for varying durations after induction of diabetes. A second group of age-matched control rats was maintained in a parallel manner. Kinetic analysis of tetraethylammonium accumulation in freshly isolated proximal tubular cells indicated a significantly lower V(max) value for the diabetics versus controls with no statistical difference in K(m) values between the two groups. Cortex sections were processed by standard procedures for Northern and immunoblot analysis. Protein expression of the organic cation transporters rOCT1 and rOCT2 progressively decreased with increasing duration of diabetes. After 21 days of diabetes, rOCT1 and rOCT2 were maximally reduced by 50 and 70%, respectively. Quantification of mRNA expression revealed that the roct1 transcript remained unchanged, whereas the roct2 transcript was decreased by 50% after 14 days of diabetes. Treatment with insulin prevented the reductions in transporter levels. These results support the hypothesis by demonstrating that experimental diabetes decreased expression of both rOCT1 and rOCT2 protein and also of roct2 mRNA accumulation. On the other hand, roct1 mRNA levels were unaffected by the diabetic state. This suggests that differences in rOCT2 protein may result from transcriptional and/or translational changes, whereas rOCT1 deficits may be due to posttranscriptional alterations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14718608     DOI: 10.1124/jpet.103.058388

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  21 in total

Review 1.  Regulation of organic cation transport.

Authors:  Giuliano Ciarimboli; Eberhard Schlatter
Journal:  Pflugers Arch       Date:  2004-11-16       Impact factor: 3.657

Review 2.  Renal Drug Transporters and Drug Interactions.

Authors:  Anton Ivanyuk; Françoise Livio; Jérôme Biollaz; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

3.  Prenatal metformin exposure or organic cation transporter 3 knock-out curbs social interaction preference in male mice.

Authors:  Valentina R Garbarino; Taylor A Santos; Anastassia R Nelson; Wynne Q Zhang; Corey M Smolik; Martin A Javors; Lynette C Daws; Georgianna G Gould
Journal:  Pharmacol Res       Date:  2018-11-10       Impact factor: 7.658

Review 4.  Endocrine and metabolic regulation of renal drug transporters.

Authors:  Lindsay L Yacovino; Lauren M Aleksunes
Journal:  J Biochem Mol Toxicol       Date:  2012-08-29       Impact factor: 3.642

5.  Quercetin regulates organic ion transporter and uromodulin expression and improves renal function in hyperuricemic mice.

Authors:  Qing-Hua Hu; Xian Zhang; Xing Wang; Rui-Qing Jiao; Ling-Dong Kong
Journal:  Eur J Nutr       Date:  2011-09-10       Impact factor: 5.614

6.  Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2.

Authors:  Giuliano Ciarimboli; Thomas Ludwig; Detlef Lang; Hermann Pavenstädt; Hermann Koepsell; Hans-Jürgen Piechota; Jörg Haier; Ulrich Jaehde; Jochen Zisowsky; Eberhard Schlatter
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

7.  Protein kinase inhibition differentially regulates organic cation transport.

Authors:  Alexander M Gerlyand; Daniel S Sitar
Journal:  Can J Physiol Pharmacol       Date:  2009-10       Impact factor: 2.273

8.  Urine NGAL and KIM-1 in children and adolescents with hyperuricemia.

Authors:  Justyna Tomczak; Anna Wasilewska; Robert Milewski
Journal:  Pediatr Nephrol       Date:  2013-05-15       Impact factor: 3.714

Review 9.  Altered Expression of Transporters, its Potential Mechanisms and Influences in the Liver of Rodent Models Associated with Diabetes Mellitus and Obesity.

Authors:  Leilei Ma; Lei He; Le Wang; Li Li; Xuena Lin; Guoyu Pan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-06       Impact factor: 2.441

Review 10.  Extreme enhancement or depletion of serotonin transporter function and serotonin availability in autism spectrum disorder.

Authors:  Valentina R Garbarino; T Lee Gilman; Lynette C Daws; Georgianna G Gould
Journal:  Pharmacol Res       Date:  2018-07-24       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.